Mitchell Sinkler & Starr’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$974K Buy
2,310
+15
+0.7% +$5.98K 0.39% 54
2026
Q2
$831K Hold
2,295
– – 0.35% 62
2026
Q1
$807K Hold
2,295
– – 0.37% 63
2025
Q4
$751K Sell
2,295
-40
-2% -$12.7K 0.34% 67
2025
Q3
$659K Hold
2,335
– – 0.3% 75
2025
Q2
$652K Hold
2,335
– – 0.31% 75
2025
Q1
$727K Sell
2,335
-1,750
-43% -$517K 0.2% 80
2024
Q4
$1.06M Hold
4,085
– – 0.28% 66
2024
Q3
$1.32M Buy
4,085
+105
+3% +$34.3K 0.33% 63
2024
Q2
$1.32M Buy
3,980
+180
+5% +$52.9K 0.34% 63
2024
Q1
$1.08M Buy
3,800
+895
+31% +$262K 0.27% 72
2023
Q4
$837K Buy
2,905
+600
+26% +$163K 0.15% 105
2023
Q3
$619K Buy
2,305
+70
+3% +$17.5K 0.19% 73
2023
Q2
$496K Sell
2,235
-70
-3% -$16.2K 0.14% 95
2023
Q1
$557K Buy
+2,305
New +$566K 0.16% 88

Other funds holding AMGN

Mitchell Sinkler & Starr's AMGN Position: Q3 2026 in Review

Mitchell Sinkler & Starr increased its Amgen (AMGN) stake by 0.65% in Q3 2026, buying an estimated $5.98K and bringing the position to 2,310 shares worth $974K. The position accounts for 0.39% of the portfolio, ranked #54.

Mitchell Sinkler & Starr first reported a position in AMGN in Q1 2023 and has held it in 15 quarters since. The position peaked at $1.32M in Q2 2024. 965 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Mitchell Sinkler & Starr held 2,310 shares of Amgen worth $974K as of Q3 2026.
  • Mitchell Sinkler & Starr bought 15 Amgen shares in Q3 2026, an estimated $5.98K.
  • Amgen made up 0.39% of Mitchell Sinkler & Starr's portfolio in Q3 2026, its #54 holding.
  • Mitchell Sinkler & Starr first reported a position in Amgen in Q1 2023 and has held it in 15 quarters since.
  • Mitchell Sinkler & Starr's Amgen position peaked at $1.32M in Q2 2024.
  • 965 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q3 2026, filed 13 Oct 2026.